Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies

Molecular screening tools have significantly eased the assessment of potential germline susceptibility factors that may underlie the development of pediatric malignancies. Most of the hitherto published studies utilize the comparative analyses of the respective patients' germline and tumor tiss...

Full description

Bibliographic Details
Main Authors: Triantafyllia Brozou, Layal Yasin, Danielle Brandes, Daniel Picard, Carolin Walter, Julian Varghese, Martin Dugas, Ute Fischer, Arndt Borkhardt, Oskar A. Haas
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1080347/full
_version_ 1811170413279969280
author Triantafyllia Brozou
Layal Yasin
Danielle Brandes
Daniel Picard
Carolin Walter
Julian Varghese
Martin Dugas
Ute Fischer
Arndt Borkhardt
Oskar A. Haas
author_facet Triantafyllia Brozou
Layal Yasin
Danielle Brandes
Daniel Picard
Carolin Walter
Julian Varghese
Martin Dugas
Ute Fischer
Arndt Borkhardt
Oskar A. Haas
author_sort Triantafyllia Brozou
collection DOAJ
description Molecular screening tools have significantly eased the assessment of potential germline susceptibility factors that may underlie the development of pediatric malignancies. Most of the hitherto published studies utilize the comparative analyses of the respective patients' germline and tumor tissues for this purpose. Since this approach is not able to discriminate between de novo and inherited sequence variants, we performed whole exome trio analyses in a consecutive series of 131 children with various forms of hematologic malignancies and their parents. In total, we identified 458 de novo variants with a range from zero to 28 (median value = 3) per patient, although most of them (58%) had only up to three per exome. Overall, we identified bona fide cancer predisposing alterations in five of the investigated 131 (3.8%) patients. Three of them had de novo pathogenic lesions in the SOS1, PTPN11 and TP53 genes and two of them parentally inherited ones in the STK11 and PMS2 genes that are specific for a Peutz-Jeghers and a constitutional mismatch repair deficiency (CMMRD) syndrome, respectively. Notwithstanding that we did not identify a disease-specific alteration in the two cases with the highest number of de novo variants, one of them developed two almost synchronous malignancies: a myelodysplastic syndrome and successively within two months a cerebral astrocytoma. Moreover, we also found that the rate of de novo sequence variants in the offspring increased especially with the age of the father, but less so with that of the mother. We therefore conclude that trio analyses deliver an immediate overview about the inheritance pattern of the entire spectrum of sequence variants, which not only helps to securely identify the de novo or inherited nature of genuinely disease-related lesions, but also of all other less obvious variants that in one or the other way may eventually advance our understanding of the disease process.
first_indexed 2024-04-10T16:56:21Z
format Article
id doaj.art-6708bfe8cbf947749a0cbf40b25fba82
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-10T16:56:21Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-6708bfe8cbf947749a0cbf40b25fba822023-02-07T06:10:35ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-02-011010.3389/fped.2022.10803471080347Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignanciesTriantafyllia Brozou0Layal Yasin1Danielle Brandes2Daniel Picard3Carolin Walter4Julian Varghese5Martin Dugas6Ute Fischer7Arndt Borkhardt8Oskar A. Haas9Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyInstitute of Medical Informatics, University of Münster, Münster, GermanyInstitute of Medical Informatics, University of Münster, Münster, GermanyInsititute of Medical Informatics, Heidelberg University Hospital, Heidelberg, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanySt. Anna Children's Hospital, Pediatric Clinic, Medical University, Vienna, AustriaMolecular screening tools have significantly eased the assessment of potential germline susceptibility factors that may underlie the development of pediatric malignancies. Most of the hitherto published studies utilize the comparative analyses of the respective patients' germline and tumor tissues for this purpose. Since this approach is not able to discriminate between de novo and inherited sequence variants, we performed whole exome trio analyses in a consecutive series of 131 children with various forms of hematologic malignancies and their parents. In total, we identified 458 de novo variants with a range from zero to 28 (median value = 3) per patient, although most of them (58%) had only up to three per exome. Overall, we identified bona fide cancer predisposing alterations in five of the investigated 131 (3.8%) patients. Three of them had de novo pathogenic lesions in the SOS1, PTPN11 and TP53 genes and two of them parentally inherited ones in the STK11 and PMS2 genes that are specific for a Peutz-Jeghers and a constitutional mismatch repair deficiency (CMMRD) syndrome, respectively. Notwithstanding that we did not identify a disease-specific alteration in the two cases with the highest number of de novo variants, one of them developed two almost synchronous malignancies: a myelodysplastic syndrome and successively within two months a cerebral astrocytoma. Moreover, we also found that the rate of de novo sequence variants in the offspring increased especially with the age of the father, but less so with that of the mother. We therefore conclude that trio analyses deliver an immediate overview about the inheritance pattern of the entire spectrum of sequence variants, which not only helps to securely identify the de novo or inherited nature of genuinely disease-related lesions, but also of all other less obvious variants that in one or the other way may eventually advance our understanding of the disease process.https://www.frontiersin.org/articles/10.3389/fped.2022.1080347/fullpediatric hematological malignanciestrio-whole-exome sequencingcancer predisposition syndromeinheritance patternde novo mutations
spellingShingle Triantafyllia Brozou
Layal Yasin
Danielle Brandes
Daniel Picard
Carolin Walter
Julian Varghese
Martin Dugas
Ute Fischer
Arndt Borkhardt
Oskar A. Haas
Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
Frontiers in Pediatrics
pediatric hematological malignancies
trio-whole-exome sequencing
cancer predisposition syndrome
inheritance pattern
de novo mutations
title Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
title_full Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
title_fullStr Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
title_full_unstemmed Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
title_short Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
title_sort resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies
topic pediatric hematological malignancies
trio-whole-exome sequencing
cancer predisposition syndrome
inheritance pattern
de novo mutations
url https://www.frontiersin.org/articles/10.3389/fped.2022.1080347/full
work_keys_str_mv AT triantafylliabrozou resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT layalyasin resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT daniellebrandes resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT danielpicard resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT carolinwalter resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT julianvarghese resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT martindugas resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT utefischer resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT arndtborkhardt resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies
AT oskarahaas resolvinginheritedanddenovogermlinepredisposingsequencevariantsbymeansofwholeexometrioanalysesinchildhoodhematologicalmalignancies